Determines outcome or prognosis of breast cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy11

Breast Cell Line, Tumor MCF-7 Cells Tumor Cells, Cultured Axilla Mammary Glands, Human Lymph Nodes Neoplastic Stem Cells Nipples Neoplastic Cells, Circulating Epithelial Cells

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases46

Breast Neoplasms Carcinoma, Ductal, Breast Breast Diseases Neoplasm Metastasis Neoplasm Invasiveness Breast Neoplasms, Male Carcinoma, Lobular Neoplasm Recurrence, Local Carcinoma Lymphatic Metastasis Genetic Predisposition to Disease Carcinoma, Intraductal, Noninfiltrating Disease Progression Ovarian Neoplasms Lung Neoplasms Neoplasms, Hormone-Dependent Mammary Neoplasms, Experimental Neoplasms Prostatic Neoplasms Fibrocystic Breast Disease Bone Neoplasms Stomach Neoplasms Adenocarcinoma Colonic Neoplasms Carcinoma, Ductal Cell Transformation, Neoplastic Carcinoma in Situ Neoplasms, Second Primary Pancreatic Neoplasms Triple Negative Breast Neoplasms Colorectal Neoplasms Inflammatory Breast Neoplasms Recurrence Carcinoma, Squamous Cell Neovascularization, Pathologic Uterine Cervical Neoplasms Neoplastic Cells, Circulating Fibroadenoma Liver Neoplasms Carcinoma, Non-Small-Cell Lung Endometrial Neoplasms Neoplasms, Basal Cell Neoplasms, Multiple Primary Neoplasms, Radiation-Induced Urinary Bladder Neoplasms Pregnancy Complications, Neoplastic

Chemicals and Drugs50

Receptors, Estrogen Receptor, erbB-2 Tamoxifen Receptors, Progesterone Tumor Markers, Biological Antineoplastic Agents, Hormonal Antineoplastic Agents Neoplasm Proteins Estrogen Receptor alpha Estrogens RNA, Messenger BRCA2 Protein BRCA1 Protein Aromatase Inhibitors Estrogen Antagonists DNA, Neoplasm Fluorouracil Cyclophosphamide RNA, Small Interfering Antibodies, Monoclonal, Humanized Estradiol Tumor Suppressor Protein p53 Antibodies, Monoclonal Epirubicin Estrogen Receptor Modulators Ki-67 Antigen Selective Estrogen Receptor Modulators Nitriles Receptor, Epidermal Growth Factor Tumor Suppressor Proteins Antigens, Neoplasm RNA, Neoplasm Paclitaxel Cancer Vaccines Mucin-1 Transcription Factors Antigens, CD24 MicroRNAs Triazoles Anticarcinogenic Agents Anthracyclines DNA-Binding Proteins Antibiotics, Antineoplastic Doxorubicin Methotrexate Proto-Oncogene Proteins Proto-Oncogene Proteins c-akt Cisplatin Nuclear Proteins Cyclin D1

Analytical, Diagnostic and Therapeutic Techniques and Equipment81

Prognosis Treatment Outcome Mammography Risk Factors Neoplasm Staging Follow-Up Studies Retrospective Studies Survival Analysis Survival Rate Prospective Studies Mastectomy Early Detection of Cancer Chemotherapy, Adjuvant Immunohistochemistry Antineoplastic Combined Chemotherapy Protocols Case-Control Studies Disease-Free Survival Risk Assessment Gene Expression Profiling Cohort Studies Multivariate Analysis Risk Kaplan-Meier Estimate Predictive Value of Tests Incidence Reverse Transcriptase Polymerase Chain Reaction Mammary Neoplasms, Experimental Breast Self-Examination Odds Ratio Registries Mastectomy, Segmental Combined Modality Therapy Sensitivity and Specificity Proportional Hazards Models Logistic Models Blotting, Western Pregnancy Outcome Xenograft Model Antitumor Assays Tissue Array Analysis Oligonucleotide Array Sequence Analysis Reproducibility of Results Neoplasm Transplantation Neoplasm Grading Transplantation, Heterologous Tumor Burden Ultrasonography, Mammary Clinical Trials as Topic SEER Program Immunoenzyme Techniques Confidence Intervals Radiotherapy, Adjuvant Questionnaires Polymerase Chain Reaction Mass Screening Breast Implants Biopsy Transfection Neoadjuvant Therapy Mammaplasty Radiotherapy Biopsy, Needle Genetic Testing Molecular Targeted Therapy Chi-Square Distribution In Situ Hybridization, Fluorescence Randomized Controlled Trials as Topic Regression Analysis Drug Screening Assays, Antitumor Lymph Node Excision Drug Administration Schedule Sentinel Lymph Node Biopsy Gene Knockdown Techniques Pilot Projects Estrogen Replacement Therapy Models, Biological DNA Mutational Analysis Analysis of Variance Research Design Mastectomy, Radical Probability Severity of Illness Index

Psychiatry and Psychology3

Breast Feeding Breast Self-Examination Smoking

Phenomena and Processes52

Gene Expression Regulation, Neoplastic Genes, BRCA1 Postmenopause Time Factors Genetic Predisposition to Disease Drug Resistance, Neoplasm Risk Breast Feeding Premenopause Cell Proliferation Odds Ratio Menopause Genes, BRCA2 Genes, erbB-2 Mutation Sensitivity and Specificity Apoptosis Signal Transduction Pregnancy Outcome Genotype Cell Movement Cell Division Down-Regulation Polymorphism, Genetic DNA Methylation Germ-Line Mutation Gene Amplification Promoter Regions, Genetic Dose-Response Relationship, Drug Cell Growth Processes Pregnancy Up-Regulation Transfection Cell Cycle RNA Interference Parity Phenotype Gene Expression Chi-Square Distribution Gene Silencing Cell Survival Genes, Neoplasm Genes, Tumor Suppressor Genes, p53 Base Sequence Phosphorylation Epithelial-Mesenchymal Transition Alleles Polymorphism, Single Nucleotide Diet Heterozygote Probability

Disciplines and Occupations4

Immunohistochemistry Outcome Assessment (Health Care)Medical Oncology Research Design

Anthropology, Education, Sociology and Social Phenomena3

Quality of Life Age Distribution National Cancer Institute (U.S.)

Humanities1

Quality of Life

Information Science7

Survival Rate Incidence Registries SEER Program Questionnaires Base Sequence Molecular Sequence Data

Named Groups4

Survivors European Continental Ancestry Group African Americans Infant, Newborn

Health Care42

Treatment Outcome Risk Factors Follow-Up Studies Retrospective Studies Survival Analysis Survival Rate Prospective Studies Outcome Assessment (Health Care)Case-Control Studies Disease-Free Survival Risk Assessment Cohort Studies Age Factors Multivariate Analysis Risk Kaplan-Meier Estimate Predictive Value of Tests Incidence Odds Ratio Registries Sensitivity and Specificity Proportional Hazards Models Logistic Models Reproducibility of Results Clinical Trials as Topic SEER Program Confidence Intervals Questionnaires Mass Screening Parity Genetic Testing Chi-Square Distribution Randomized Controlled Trials as Topic Regression Analysis Pilot Projects Age of Onset Analysis of Variance Outcome and Process Assessment (Health Care)Age Distribution National Cancer Institute (U.S.)Probability Severity of Illness Index

Geographicals4

United States China Japan Sweden

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Prognosis Breast Breast Neoplasms Carcinoma, Ductal, Breast Receptors, Estrogen Treatment Outcome Cell Line, Tumor Receptor, erbB-2 Breast Diseases Gene Expression Regulation, Neoplastic Tamoxifen Receptors, Progesterone Tumor Markers, Biological Neoplasm Metastasis Mammography Neoplasm Invasiveness Risk Factors Neoplasm Staging Follow-Up Studies Retrospective Studies Survival Analysis Survival Rate Breast Neoplasms, Male Prospective Studies Antineoplastic Agents, Hormonal Antineoplastic Agents Neoplasm Proteins Mastectomy Early Detection of Cancer Chemotherapy, Adjuvant Genes, BRCA1 Immunohistochemistry Postmenopause Carcinoma, Lobular Time Factors Antineoplastic Combined Chemotherapy Protocols Outcome Assessment (Health Care)Case-Control Studies Disease-Free Survival Neoplasm Recurrence, Local Risk Assessment Carcinoma Lymphatic Metastasis Genetic Predisposition to Disease Carcinoma, Intraductal, Noninfiltrating Gene Expression Profiling Mice, Nude Cohort Studies Age Factors Disease Progression Drug Resistance, Neoplasm MCF-7 Cells Multivariate Analysis Risk Breast Feeding Tumor Cells, Cultured Ovarian Neoplasms Kaplan-Meier Estimate Premenopause Estrogen Receptor alpha Cell Proliferation Lung Neoplasms Estrogens Predictive Value of Tests Incidence Neoplasms, Hormone-Dependent Reverse Transcriptase Polymerase Chain Reaction Mammary Neoplasms, Experimental Breast Self-Examination Odds Ratio Neoplasms RNA, Messenger Menopause BRCA2 Protein Survivors United States Registries Genes, BRCA2 BRCA1 Protein Prostatic Neoplasms Aromatase Inhibitors Genes, erbB-2 Fibrocystic Breast Disease Estrogen Antagonists DNA, Neoplasm Axilla Mastectomy, Segmental Mutation Combined Modality Therapy Sensitivity and Specificity Proportional Hazards Models Logistic Models Mammary Glands, Human Bone Neoplasms Blotting, Western Apoptosis Signal Transduction Pregnancy Outcome Xenograft Model Antitumor Assays Tissue Array Analysis

No FAQ available that match "determines outcome or prognosis of breast cancer"